Radiopharmaceutical Therapy

BOSTON, Mass. — September 27, 2026 ITM Isotope Technologies Munich SE and Lumara Bio announced new real-world re-treatment and...

Garching/Munich, Germany and Princeton, New Jersey, August 10, 2026 ITM Isotope Technologies Munich SE (ITM) announced that the U.S....

MELBOURNE, Australia, and INDIANAPOLIS, Ind., July 21, 2026 Telix Pharmaceuticals announced that the first patient has been dosed in...

MELBOURNE, Australia & INDIANAPOLIS, U.S., June 2, 2026 Telix Pharmaceuticals announced positive Part 1 data from its global Phase...

Melbourne, Australia & Indianapolis, United States – March 10, 2026 Telix Pharmaceuticals has announced that Part 1 of the...

February 25, 2026 – Garching / Munich, Germany ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotechnology company, has...